Since 1938 bypasses cell-surface receptors to activate the RISK pathway by directly binding PI3Kα, we hypothesized that, in contrast to insulin, 1938 would remain cardioprotective in the setting of insulin resistance. This evidence concerns the gene INS and Insulin resistance.